KEAP1 and breast cancer: The dysregulation of the Nrf2-Keap1 signaling pathway has been observed in a broad spectrum of human malignancies, including breast cancer, and multiple downstream signaling pathways are involved in disease pathogenesis, including increased Nrf2 levels, decreased Keap1 levels, and blocked Nrf2 ubiquitination.